The alliance will allow MedStar Health to extend its cancer care services and provide symptom management, remote patient monitoring and supportive care.
The company's minimally invasive muscle-machine interface, Phantom X, allows one to control prosthetic limbs and robotic exoskeletons as extensions of the human body.
The G7 continuous glucose monitoring system will have a 15.5-day wear time and last 15% longer than Dexcom G7, according to the company.
Two new memos update federal AI policy, which the White House says will accelerate innovation, strengthen public trust and prioritize U.S.-developed AI tools.
The study has demonstrated the potential of predictable movement stimuli as a behavioural marker of autism spectrum disorder.
A study published in the European Journal of Cancer says inaccurate results and misdiagnoses could occur if diverse populations are not included in clinical research.
The Health Tech Investment Act would establish a reimbursement pathway for FDA-cleared AI-enabled medical devices.
The company's technology enables gesture recognition by detecting subtle muscle movements without skin contact.
